GANGLIOSIDE STUDIES
GANGLIOSIDE STUDIES
批准号:
3409754
负责人:
THOMAS N SEYFRIED
金额:
$7.23万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1987
资助国家:
美国
项目状态:
已结题
起止时间:
1987-04-01 至 1993-03-31
关键词:
N acetylgalactosamine disease /disorder model embryo /fetus enzyme substrate exo alpha sialidase gangliosides gangliosidosis gas chromatography glycolipids glycosyltransferase high performance liquid chromatography laboratory mouse lipid biosynthesis mammalian embryology monoclonal antibody mutant neurogenesis point mutation thin layer chromatography
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The goal of this research is to clarify the nature of ganglioside
abnormalities in mutant mouse embryos. Gangliosides are a family of sialic
acid-containing glycosphingolipids that are enriched in the central nervous
system (CNS) and are thought to play an important role in neuronal
differentiation. The tW1 mouse mutation is located within the T/t complex
on chromosome 17 and causes embryonic lethality from failed neuronal
differentiation within the neural tube. Recent findings indicate the
tW1/tW1 embryos express reductions of gangliosides in the "b" metabolic
pathway (GD3, GD1b, GT1b, and GQ1b) and elevations of ganglioside in the
"a" metabolic pathway (GM3, GM2, GM1, and GD1a). This shift in ganglioside
distribution strongly suggests that the mutants have a partial deficiency
in the sialyltransferase activity that catalyzes the synthesis of GD3 from
GM3: a key enzyme in the synthesis of the complex gangliosides. Moreover,
gangliosides of the "b" pathway have been implicated in neuronal
differentiation and neuritogenesis. This hypothesis will be tested through
a developmental analysis of ganglioside composition and metabolism in
normal and tW1/tW1 mutants. The gangliosides will be studied from
embryonic day 13 (E-13) to E-17 in whole embryos and in embryonic CNS
tissues. The composition of neutral glycolipids will also be examined.
Total ganglioside content will be analyzed using gas-liquid chromatography
and the individual ganglioside species will be analyzed using high
performance thin-layer chromatography and densitometry. A specific
objective will be to determine if the ganglioside abnormalities are a
primary or secondary effect of the tW1 mutation. This will be approached
through in vivo and in vitro studies of ganglioside biosynthesis in the +/+
and tW1/tW1 embryos and in the phenotypically normal +/tW1 heterozygotes.
The sialyltransferase activities that catalyze the synthesis of GM3, GD3,
GD1a, and GQ1b will be analyzed in enzyme enriched membrane preparations
from the +/+, +/tW1, and tW1/tW1 embryos. The N-
acetylgalactosaminyltransferase activity that catalyzes the synthesis of
GM2 from GM3 (a key enzyme in the synthesis of "a" pathway gangliosides)
will also be analyzed in the normal and mutant embryos. The activity of
GM1 beta-galactosidase will also be studied using GM1 as a natural
substrate in embryos of inbred DBA/2 and C57BL/6 mice and their F1 hybrids.
Because DBA mice have elevated levels of GM1 at both embryonic and juvenile
ages, they may express a mild form of GM1 gangliosidosis and serve as an
important animal model for this disorder. Since this is the first study of
ganglioside abnormalities associated with inherited embryonic lethality and
failed CNS development in mammals, new insight can be obtained on
ganglioside function and on the genetic regulation of ganglioside
metabolism.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Glycosphingolipid Effects on Brain Tumor Angiogenesis
-
批准号:6891290
-
项目类别:
-
资助金额:$24.33万
-
财政年份:2004
-
负责人:THOMAS N SEYFRIED
-
依托单位:
Glycosphingolipid Effects on Brain Tumor Angiogenesis
-
批准号:6777814
-
项目类别:
-
资助金额:$25.33万
-
财政年份:2004
-
负责人:THOMAS N SEYFRIED
-
依托单位:
Glycosphingolipid Effects on Brain Tumor Angiogenesis
-
批准号:7061813
-
项目类别:
-
资助金额:$23.76万
-
财政年份:2004
-
负责人:THOMAS N SEYFRIED
-
依托单位:
GLYCOSPHINGOLIPIDS IN MURINE NEURODEGENERATIVE DISEASES
-
批准号:6226974
-
项目类别:
-
资助金额:$23.47万
-
财政年份:2001
-
负责人:THOMAS N SEYFRIED
-
依托单位:
GLYCOSPHINGOLIPIDS IN MURINE NEURODEGENERATIVE DISEASES
-
批准号:6685220
-
项目类别:
-
资助金额:$20.59万
-
财政年份:2001
-
负责人:THOMAS N SEYFRIED
-
依托单位:
Glycosphingolipids in murine neurodegenerative diseases
-
批准号:7362400
-
项目类别:
-
资助金额:$39.99万
-
财政年份:2001
-
负责人:THOMAS N SEYFRIED
-
依托单位:
Glycosphingolipids in murine neurodegenerative diseases
-
批准号:7144285
-
项目类别:
-
资助金额:$25.89万
-
财政年份:2001
-
负责人:THOMAS N SEYFRIED
-
依托单位:
GLYCOSPHINGOLIPIDS IN MURINE NEURODEGENERATIVE DISEASES
-
批准号:6625234
-
项目类别:
-
资助金额:$20.59万
-
财政年份:2001
-
负责人:THOMAS N SEYFRIED
-
依托单位:
Glycosphingolipids in Murine Neurodegenerative Diseases
-
批准号:8550181
-
项目类别:
-
资助金额:$34.65万
-
财政年份:2001
-
负责人:THOMAS N SEYFRIED
-
依托单位:
GLYCOSPHINGOLIPIDS IN MURINE NEURODEGENERATIVE DISEASES
-
批准号:6476748
-
项目类别:
-
资助金额:$20.59万
-
财政年份:2001
-
负责人:THOMAS N SEYFRIED
-
依托单位:
Glycosphingolipids in murine neurodegenerative diseases
-
批准号:7564054
-
项目类别:
-
资助金额:$39.99万
-
财政年份:2001
-
负责人:THOMAS N SEYFRIED
-
依托单位:
Glycosphingolipids in murine neurodegenerative diseases
-
批准号:7280773
-
项目类别:
-
资助金额:$39.9万
-
财政年份:2001
-
负责人:THOMAS N SEYFRIED
-
依托单位:
GLYCOLIPIDS IN BRAIN TUMORS
-
批准号:6254172
-
项目类别:
-
资助金额:$1.96万
-
财政年份:1997
-
负责人:THOMAS N SEYFRIED
-
依托单位:
GLYCOLIPIDS BRAIN TUMORS
-
批准号:2272550
-
项目类别:
-
资助金额:$13.36万
-
财政年份:1995
-
负责人:THOMAS N SEYFRIED
-
依托单位:
GLYCOLIPIDS BRAIN TUMORS
-
批准号:2333009
-
项目类别:
-
资助金额:$13.88万
-
财政年份:1995
-
负责人:THOMAS N SEYFRIED
-
依托单位:
GLYCOLIPIDS BRAIN TUMORS
-
批准号:2272549
-
项目类别:
-
资助金额:$14.18万
-
财政年份:1995
-
负责人:THOMAS N SEYFRIED
-
依托单位:
GANGLIOSIDE STUDIES
-
批准号:3409757
-
项目类别:
-
资助金额:$1.77万
-
财政年份:1987
-
负责人:THOMAS N SEYFRIED
-
依托单位:
GANGLIOSIDE STUDIES IN EMBRYOS
-
批准号:3409752
-
项目类别:
-
资助金额:$8.87万
-
财政年份:1987
-
负责人:THOMAS N SEYFRIED
-
依托单位:
GANGLIOSIDE STUDIES
-
批准号:3409759
-
项目类别:
-
资助金额:$11.62万
-
财政年份:1987
-
负责人:THOMAS N SEYFRIED
-
依托单位:
GANGLIOSIDE STUDIES IN EMBRYOS
-
批准号:3409758
-
项目类别:
-
资助金额:$6.95万
-
财政年份:1987
-
负责人:THOMAS N SEYFRIED
-
依托单位: